recurrent mantle cell lymphoma

Showing NaN - NaN of 12

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma Trial in

Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +13 more
  • Polatuzumab Vedotin
  • +3 more
  • Scottsdale, Arizona
  • +11 more
Aug 23, 2022

Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Seattle (Nivolumab)

Recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +17 more
  • Nivolumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Post-Transplant Lymphoproliferative Disorder, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Seattle

Not yet recruiting
  • Post-Transplant Lymphoproliferative Disorder
  • +10 more
  • Loncastuximab Tesirine
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

Terminated
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +12 more
  • Laboratory Biomarker Analysis
  • ROR1 CAR-specific Autologous T-Lymphocytes
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 7, 2022

Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in

Completed
  • Contiguous Stage II Mantle Cell Lymphoma
  • +5 more
  • Duarte, California
  • +1 more
Jan 12, 2022

Ann Arbor Stage I Mantle Cell Lymphoma, Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma Trial

Terminated
  • Ann Arbor Stage I Mantle Cell Lymphoma
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 16, 2021

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Seattle (procedure,

Completed
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 29, 2020

Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +115 more
  • Fludarabine Phosphate
  • +6 more
  • Denver, Colorado
  • +10 more
Oct 29, 2019

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +67 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 17, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +96 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 10, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +88 more
  • palifermin
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 19, 2014

Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +84 more
  • sunitinib malate
  • +2 more
  • Los Angeles, California
  • +10 more
Mar 14, 2014